Denali Therapeutics
DNLI
18.45
+0.25
+1.37%
Denali Therapeutics
US · DNLI
#2454 by market cap
Listed 2017
18.45
+0.25
+1.37%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Quant vs Street three independent views, side by side
StockVane factor grade
B-
Momentum strategy signal
Sell
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Analyst consensus 7 analysts
Buy
Avg price target 35.33 +91.5%
Price target rangecurrent 18.45
Low24.00
Avg35.33
High42.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-13 | Wells Fargo | -- | Buy | 35.00 |
| 2026-11-13 | Morgan Stanley | -- | Buy | 37.00 |
| 2026-11-04 | BofA Securities | -- | Buy | -- |
| 2026-11-04 | Wedbush | -- | Buy | 24.00 |
| 2026-11-04 | Morgan Stanley | -- | Buy | 42.00 |
| 2026-11-04 | B. Riley Securities | -- | Buy | 35.00 |
| 2026-11-04 | H.C. Wainwright | -- | Buy | 42.00 |
| 2026-11-03 | BTIG | -- | Buy | 39.00 |
| 2026-08-25 | B. Riley Securities | -- | Buy | 35.00 |
| 2026-08-11 | J.P. Morgan | -- | Buy | 29.00 |
| 2026-08-07 | William Blair | -- | Buy | -- |
| 2026-08-07 | UBS | -- | Buy | 34.00 |
| 2026-08-07 | BofA Securities | -- | Buy | 31.00 |
| 2026-08-07 | Baird | -- | Buy | 34.00 |
| 2026-08-07 | Morgan Stanley | -- | Buy | 40.00 |
| 2026-08-07 | Stifel | -- | Buy | 41.00 |
| 2026-08-07 | H.C. Wainwright | -- | Buy | 42.00 |
| 2026-08-06 | TD Cowen | -- | Buy | -- |
| 2026-08-06 | BTIG | -- | Buy | 39.00 |
| 2026-07-23 | Morgan Stanley | -- | Buy | 36.00 |
| 2026-07-16 | Deutsche Bank | -- | Buy | 35.00 |
| 2026-07-15 | BofA Securities | -- | Buy | 31.00 |
| 2026-07-13 | Wedbush | -- | Buy | 26.00 |
| 2026-07-13 | H.C. Wainwright | -- | Buy | 42.00 |
| 2026-07-13 | J.P. Morgan | -- | Buy | 29.00 |
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-11-03 | After close | ±15.81% | +7.76% (in line) |
| 2026/Q2 | 2026-08-06 | After close | ±11.30% | +0.40% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 20:02:19 · For reference only, not investment advice and not tailored to your situation.
Denali Therapeutics discussion 0 comments